Posts Tagged ‘Brian Van Tine’
Now that many states and localities are starting to lift shelter-in-place restrictions and move into phases of reopening, what do sarcoma patients need to know? As a follow-up to our April session, the Sarcoma Foundation of America is reuniting the panel of sarcoma experts to share their thoughts on how COVID-19 may continue to impact care and what sarcoma patients need to know as we begin the phases of reopening. Our multidisciplinary panel will answer your questions and address concerns on issues of care, the impact on research and clinical trials, and next steps as we move forward. Saturday,… Read More »
In response to the COVID-19 outbreak, the Sarcoma Foundation of America (SFA) held a live, online session with a panel of sarcoma experts to discuss the impact the coronavirus pandemic is having on sarcoma patients and survivors. Panelists Brian Van Tine, MD, PhD, Washington University in St. Louis, Kurt Weiss, MD, University of Pittsburgh School of Medicine, and Breelyn Wilky, MD, University of Colorado Cancer Center, answered questions submitted by the sarcoma community. The panelists shared input on issues related to how on patients can communicate with their physicians on the risks and benefits of current care and treatment… Read More »
Brian A. Van Tine, MD, PhD Assistant Professor of Medicine, Sarcoma Program Director, Washington University in St. Louis 2013 Sarcoma Foundation of America Research Grant Recipient: “A Metabolomic Approach to Targeting ASS1 Deficient Sarcomas” 2014 Sarcoma Foundation of America Research Grant Recipient: “Targeting the Pentose Phosphate Pathway for the Treatment of Synovial Sarcoma” 2017 Sarcoma Foundation of America Research Grant Recipient: “Targeting the alterations of Lipid Metabolism in ASS1 Deficient Sarcomas to Induce Synthetic Lethality” PLEASE DESCRIBE THE FOCUS OF THE RESEARCH PERFORMED IN YOUR LAB. I am an Assistant Professor of Medicine in the Department of Medicine at Washington… Read More »